<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 25 Apr 2026 11:24:41 -0400--><rss version="2.0">
    <channel>
        <title>Greenwich LifeSciences, Inc. (GLSI) Press Releases</title>
        <link>https://investor.greenwichlifesciences.com/news-events/press-releases/rss</link>
        <description>Please specify a description for this RSS Feed</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/greenwichlifesciences/files/theme/images/logo-sm-v3.png</url>
                <title>Greenwich LifeSciences, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/124/greenwich-lifesciences-announces-acceptance-of-abstract-at</link>
                <pubDate>Thu, 23 Apr 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/124/greenwich-lifesciences-announces-acceptance-of-abstract-at</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/123/greenwich-lifesciences-announces-receipt-of-nasdaq-notice</link>
                <pubDate>Wed, 22 Apr 26 17:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/123/greenwich-lifesciences-announces-receipt-of-nasdaq-notice</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/122/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial</link>
                <pubDate>Mon, 20 Apr 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/122/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update on Financing Strategy]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/121/greenwich-lifesciences-provides-update-on-financing-strategy</link>
                <pubDate>Tue, 14 Apr 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/121/greenwich-lifesciences-provides-update-on-financing-strategy</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/120/greenwich-lifesciences-provides-update-on-patent-claims</link>
                <pubDate>Tue, 07 Apr 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/120/greenwich-lifesciences-provides-update-on-patent-claims</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/119/greenwich-lifesciences-announces-addition-of-city-of-hope</link>
                <pubDate>Thu, 19 Mar 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/119/greenwich-lifesciences-announces-addition-of-city-of-hope</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update on Upcoming AACR Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/118/greenwich-lifesciences-provides-update-on-upcoming-aacr</link>
                <pubDate>Wed, 18 Mar 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/118/greenwich-lifesciences-provides-update-on-upcoming-aacr</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/117/greenwich-lifesciences-provides-update-showing-continued</link>
                <pubDate>Tue, 17 Mar 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/117/greenwich-lifesciences-provides-update-showing-continued</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/116/greenwich-lifesciences-announces-use-of-commercially</link>
                <pubDate>Mon, 16 Mar 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/116/greenwich-lifesciences-announces-use-of-commercially</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/115/greenwich-lifesciences-provides-update-on-increased-patient</link>
                <pubDate>Tue, 03 Mar 26 06:00:00 -0500</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/115/greenwich-lifesciences-provides-update-on-increased-patient</guid>
                                                                            </item>
            </channel>
</rss>